Skip to content

Active Surveillance of Papillary Thyroid MicroCarcinoma

Comparison of immediate lobectomy and active surveillance in papillary thyroid microcarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004935
Enrollment
2000
Registered
2020-04-17
Start date
2020-08-03
Completion date
Unknown
Last updated
2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age 19-79 years 2) Thyroid nodules sized 6-10 mm by ultrasound within three months 3) Thyriod nodules confirmed by fine needle biopsy guided ultrosound or core needle biopsy as having Bethesda category V or VI cytology (or histopathology) within 1 year. : If cytology (or histopathology) showed Bethesda category V, the nodule should show high suspicion ultrasound features by K-TIRADS system or have BRAF V600E mutation.

Exclusion criteria

Exclusion criteria: 1) People who have difficulty understanding the study (e.g. an illiterate, decreased vision) 2) Pregnant 3) People having other chronic disease or other uncontrolled cancers - Excluding eGFR<30mL/min/1.73m2 - Other condition can be enrolled if it doesn't affect PTMC treatment progress and result by the investigator's decision. 4) People who need total thyroidectomy due to multiple nodules or other thyroid disease 5) Thyroid nodules showing (suspecting) metastases, invasion to extrathyroidal organs, bronchus, muscles or nurves(vocal cords paralysis)

Design outcomes

Primary

MeasureTime frame
Progression Free Survival

Secondary

MeasureTime frame
Overall survival according to the treatment;Risk factors of disease progression during active surveillance: age, sex, and ultrasound features;Proportion of patients who change their treatment option from active surveillance to surgery without disease progression: Analyze reasons for changing of mind by questionnaires;Changes in quality of life questionnaire scores according to the treatment and follow-up periods;Cost-effective analysis according to the treatment;Surgical outcomes analysis according to the treatment: Extent of surgery, complications of surgery;Appropriate courses(intervals) for imaging during active surveillance

Countries

Korea, Republic of

Contacts

Public ContactYunJung Kim

Asan Medical Center

yunjung.kim@amc.seoul.kr+82-2-3010-7190

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 5, 2026